Krieg Carsten, Nowicka Malgorzata, Guglietta Silvia, Schindler Sabrina, Hartmann Felix J, Weber Lukas M, Dummer Reinhard, Robinson Mark D, Levesque Mitchell P, Becher Burkhard
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Department of Microbiology and Immunology and Department of Dermatology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Nat Med. 2018 Nov;24(11):1773-1775. doi: 10.1038/s41591-018-0094-7.
In the version of this article initially published, Figs. 5a,c and 6a were incorrect because of an error in a metadata spreadsheet that led to the healthy donor patient 2 (HD2) samples being used twice in the analysis of baseline samples and in the analysis at 12 weeks of anti-PD-1 therapy, while HD3 samples had not been used.
在本文最初发表的版本中,图5a、c和图6a有误,原因是元数据电子表格中的一个错误,导致健康供体患者2(HD2)的样本在基线样本分析和抗PD-1治疗12周时的分析中被重复使用,而HD3样本未被使用。